comparemela.com

Latest Breaking News On - Advanced rcc - Page 1 : comparemela.com

Future Perspectives and Unmet Needs in Renal Cell Carcinoma

The expert panel provides key takeaways and closing thoughts on future perspectives and unmet needs in the treatment of renal cell carcinoma.

Advanced-renal-cell-carcinoma
Unmet-needs
Renal-cell
Advanced-rcc
Nrcc
Renal-cell-carcinoma
Future-perspectives
Key-takeaways

Nivolumab Plus Cabozantinib in Non–Clear Cell RCC

David A. Braun, MD, PhD, highlights recent data focused on nivolumab plus cabozantinib in patients with non–clear cell renal cell carcinoma.

Advanced-renal-cell-carcinoma
Plus-cabozantinib
Clear-cell
Advanced-rcc
Nrcc
Renal-cell-carcinoma
Non-clear-cell-rcc
Non-clear-cell-renal-carcinoma
Cabozantinib
Nivolumab

KEYNOTE-B61: Lenvatinib Plus Pembrolizumab in Non–Clear Cell RCC

Focusing on the KEYNOTE-B61 trial evaluating lenvatinib plus pembrolizumab in the first line, a panel of medical oncologists react to clinical trial data on combination regimens in non–clear cell renal cell carcinoma.

Advanced-renal-cell-carcinoma
Lenvatinib-plus-pembrolizumab
Clear-cell
Renal-cell-carcinoma
Nrcc
Advanced-rcc
Non-clear-cell-rcc
Non-clear-cell-renal-carcinoma
Lenvatinib
Pembrolizumab
Keynote-b61

Overview of Non–Clear Cell RCC

The expert panel gives an overview of non–clear cell renal cell carcinoma, highlighting disease subtypes and treatment approaches.

Advanced-renal-cell-carcinoma
Clear-cell
Renal-cell-carcinoma
Nrcc
Advanced-rcc
Non-clear-cell-rcc
Non-clear-cell-renal-carcinoma
Papillary-rcc
Translocation-renal-cell-carcinoma
Nccrcc

Dr Merchan on Key Data Supporting Pembrolizumab-Based Regimens in Advanced RCC

Jaime R. Merchán, MD, discusses the role of pembrolizumab plus axitinib or lenvatinib in previously untreated advanced renal cell carcinoma.

Jaimer-merch
Division-of-medical-oncology
Department-of-medicine
Clinical-trials-program
University-of-miami-health-system
Sylvester-comprehensive-cancer-center
Clinical-oncology-research-program
Medical-oncology
Trials-program
Miami-health-system
Cancers-symposium

vimarsana © 2020. All Rights Reserved.